IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...
Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...
Seventeen Oxford University researchers have been awarded £5 million to develop new therapies for drug-resistant tuberculosis.
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...
In a concerning development, two female elephants at Karachi’s Safari Park, Malaika and Madhubala, have been diagnosed with ...
Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...
Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results